Home
Diagnosis
Treatment
Pathology
Women Heart attack
Women risk diseases
Women stroke Risk
Services Page
Diet
Women ER delay
Inner Ear Disease
Women Killer Disease
Autoimmune diseases
Autoimmune E-Book
Personality
Hair & Chemicals

  

Spinal Injury Green tea

Light & Drug Treatment

 Daytime sleep and Stroke risk

 Homeopathic allergy meds

 Renal failure

 New cholesterol drugs fail

 Subcutaneous IVIg PAGE.

 POLYNEUROPATHY

 Lewis-Sumner syndrome

 led therapy Studies

 Piriformis Syndrome

 Tetracycline's and pulmonary inflammation.

cited from hospital errors

 Erectile Dysfunction

IMMUNOGLOBULINS

Multifocal neuropathy

 

 

.

Special GoogleHealth Search
Alternative medical treatments read our e-book 

New Psoriasis Rx      

LasiK Dangers

No cold meds to kids, says FDA

Top Foods

Calcium supplements cause stroke in women

Vitamin D extends life   Breast Size & disease

More Young Women Dying Of Heart Disease

SLE

Shifa

 

by

To treat alcohol related issues get rid of all alcohol at once.

Start a good diet with meat fruits and vegetables and salads. This should have vitamin B6,B1 and B-12 see the vitamin page link.

For quick recovery if the nerve test shows demylination get IVIg.

    • TREATMENT OF ALCOHOLIC POLYNEUROPATHY WITH VITAMIN B COMPLEX: A RANDOMISED CONTROLLED TRIAL

      T. J. PETERS1,*, J. KOTOWICZ2, W. NYKA3, W. KOZUBSKI4, V. KUZNETSOV5, F. VANDERBIST6, S. DE NIET6, D. MARCEREUIL6 and M. COFFINER6

      1 Department of Clinical Biochemistry, Kings College, London, UK, 2 Department of Neurology, Klinika Neurologiczna z Poradnia, Wojskowy Instytut Medyczny, Warszawa, Poland, 3 Department of Neurology for Adults, Medical University of Gdansk, Gdansk, Poland, 4 Department of Neurology, University of Medical Sciences, Poznan, Poland, 5 Psychiatric Department, Kiev Medical Academy of Postgraduate Education, Kiev, Ukraine and 6 Laboratoires SMB, R&D Department, Bruxelles, Belgium.

      * Author to whom correspondence should be addressed at: Department of Clinical Biochemistry, Kings College, Denmark Hill, London SE5 9RS, UK; Tel: +44 0 208 99 81 607;

      (Received 25 April 2006; first review notified 9 May 2006; in revised form 4 July 2006; accepted 4 July 2006)

      Aims: To evaluate the therapeutic efficacy and safety of BEFACT® Forte ‘new formulation’ and BEFACT® Forte ‘old formulation’ in the treatment of sensory symptoms of alcoholic polyneuropathy. Methods: A multi-centre, randomised, double-blind, placebo-controlled study was conducted on 325 patients with sensory symptoms and signs of alcoholic polyneuropathy. Patients were randomised to the ‘old formulation’ (i.e. vitamins B1, B2, B6, and B12), ‘new formulation’ [i.e. identical to the ‘old formulation’ with additional folic acid (vitamin B9)], or placebo in a 1:1:1 ratio. One tablet of the study medication (‘new formulation’ or ‘old formulation’) or placebo was taken orally, three times a day, over a 12-week treatment period. Results: Therapeutic efficacy was assessed in 253 patients by measuring vibration perception threshold (biothesiometry), intensity of pain, sensory function, co-ordination, and reflex responses. Patients treated with the ‘new formulation’ or ‘old formulation’ showed significant improvement in the primary efficacy endpoint (vibration perception threshold at the big toe) and secondary efficacy endpoints in comparison to placebo. The active treatment groups were comparable to placebo in terms of safety.

       Conclusions: A specific vitamin B complex (with and without folic acid) significantly improved symptoms of alcoholic polyneuropathy over a 12-week treatment period.


       

      •